MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.
What was lobbied
10 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Health Issues HCR
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Medicare/Medicaid MMM
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Budget/Appropriations BUD
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Insurance INS
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Aviation/Airlines/Airports AVI
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Education EDU
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Labor Issues/Antitrust/Workplace LBR
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Medical/Disease Research/Clinical Labs MED
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Welfare WEL
Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 482 / S. 350, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for robust funding of the national newborn screening program. Advocated for increased funding for HHS Agencies
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL KENNALLY LEWIS New | — |
| PAUL MELMEYER New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.